EI
PACB icon

Ellevest Inc’s Pacific Biosciences PACB Stock Holding History

Ellevest Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-58
Closed -$672 – 1244
2023
Q1 		$672 Buy
58
+7
+14% +$70 ﹤0.01% 1638
2022
Q4 		$417 Buy
+51
New +$439 ﹤0.01% 1645
2022
Q3 		– Sell
-70
Closed – – 1788
2022
Q2 		$0 Buy
70
+50
+250% +$304 ﹤0.01% 1606
2022
Q1 		$0 Hold
20
– – ﹤0.01% 1579
2021
Q4 		$0 Sell
20
-19
-49% -$459 ﹤0.01% 1583
2021
Q3 		$1K Buy
39
+19
+95% +$563 ﹤0.01% 1299
2021
Q2 		$1K Buy
20
+14
+233% +$407 ﹤0.01% 1181
2021
Q1 		$0 Hold
6
– – ﹤0.01% 1330
2020
Q4 		$0 Buy
+6
New +$102 ﹤0.01% 1309

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ellevest Inc's PACB Position: Q2 2023 in Review

Ellevest Inc sold out of Pacific Biosciences (PACB) in Q2 2023, closing a stake of 58 shares — an estimated $672 sold.

Ellevest Inc first reported a position in PACB in Q4 2020 and held it in 9 quarters. The position peaked at $1K in Q3 2021. 272 funds tracked by Wall St. Rank hold PACB as of Q2 2023.

  • Ellevest Inc reported no remaining Pacific Biosciences position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 58 Pacific Biosciences shares in Q2 2023, an estimated $672.
  • Ellevest Inc first reported a position in Pacific Biosciences in Q4 2020 and held it in 9 quarters.
  • Ellevest Inc's Pacific Biosciences position peaked at $1K in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.